December 8, 2014 7:20 pm Merck Offers $9.5B for Cubist Lexington, Mass., life sciences company makes skin and blood antibiotics targeting drug-resistant “superbugs”. US & World Videos 2:03 Man shot by police in Raynham pointed gun at officers, bodycam footage shows 2:10 Celtics crush Heat in Game 5 to advance in NBA playoffs 3:51 Lawrence fire officials say illegal apartments are a safety concern 0:24 Police arrest man in Dorchester shooting that injured 5, including 2 kids 20:10 The faces of the Karen Read trial